company background image
002393 logo

Tianjin Lisheng PharmaceuticalLtd XSEC:002393 Stock Report

Last Price

CN¥17.71

Market Cap

CN¥4.5b

7D

0.2%

1Y

-4.3%

Updated

09 Jan, 2025

Data

Company Financials

Tianjin Lisheng Pharmaceutical Co.,Ltd.

XSEC:002393 Stock Report

Market Cap: CN¥4.5b

002393 Stock Overview

Engages in the research and development, production, and sale of pharmaceutical products in China. More details

002393 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends4/6

Rewards

Price-To-Earnings ratio (24x) is below the CN market (33.2x)

Risk Analysis

Profit margins (14.9%) are lower than last year (28%)

Unstable dividend track record


My Notes

Capture your thoughts, links and company narrative

Tianjin Lisheng Pharmaceutical Co.,Ltd. Competitors

Shanghai Xiao Fang PharmaceuticalLtd

SHSE:603207

CN¥4.7b

Teyi Pharmaceutical GroupLtd

SZSE:002728

CN¥4.6b

Hunan Fangsheng Pharmaceutical

SHSE:603998

CN¥4.1b

Shandong Jincheng Pharmaceutical Group

SZSE:300233

CN¥4.5b

Price History & Performance

Summary of share price highs, lows and changes for Tianjin Lisheng PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥17.71
52 Week HighCN¥19.44
52 Week LowCN¥12.61
Beta0.21
1 Month Change-0.23%
3 Month Change5.04%
1 Year Change-4.27%
3 Year Change14.42%
5 Year Change-10.17%
Change since IPO-45.63%

Recent News & Updates

Recent updates

Shareholder Returns

002393CN PharmaceuticalsCN Market
7D0.2%-2.4%-1.5%
1Y-4.3%-7.4%5.6%

Return vs Industry: 002393 exceeded the CN Pharmaceuticals industry which returned -6% over the past year.

Return vs Market: 002393 underperformed the CN Market which returned 6.9% over the past year.

Price Volatility

Is 002393's price volatile compared to industry and market?
002393 volatility
002393 Average Weekly Movement4.3%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement7.2%
10% most volatile stocks in CN Market11.2%
10% least volatile stocks in CN Market4.4%

Stable Share Price: 002393 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 002393's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19511,328Fujun Wangwww.lishengpharma.com

Tianjin Lisheng Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers its products in various forms comprising tablets, soft capsules, granules, flat films, pills, mixture, and injection for use in various therapeutic fields, such as nervous system, musculoskeletal, genitourinary system, antineoplastic and immune system, sensory system, systemic anti-infection, respiratory system, endocrine system, digestive system, and cardiovascular system, as well as drugs for invigorating qi and blood.

Tianjin Lisheng Pharmaceutical Co.,Ltd. Fundamentals Summary

How do Tianjin Lisheng PharmaceuticalLtd's earnings and revenue compare to its market cap?
002393 fundamental statistics
Market capCN¥4.53b
Earnings (TTM)CN¥188.41m
Revenue (TTM)CN¥1.27b

24.0x

P/E Ratio

3.6x

P/S Ratio

Is 002393 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002393 income statement (TTM)
RevenueCN¥1.27b
Cost of RevenueCN¥593.72m
Gross ProfitCN¥671.52m
Other ExpensesCN¥483.10m
EarningsCN¥188.41m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Mar 21, 2025

Earnings per share (EPS)0.74
Gross Margin53.07%
Net Profit Margin14.89%
Debt/Equity Ratio1.6%

How did 002393 perform over the long term?

See historical performance and comparison

Dividends

2.4%

Current Dividend Yield

58%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/09 08:42
End of Day Share Price 2025/01/09 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tianjin Lisheng Pharmaceutical Co.,Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Peng YanChangjiang Securities Co. LTD.
Jie YaoEverbright Securities Co. Ltd.
Ting HuangSinolink Securities Co., Ltd.